[Ondansetron--a 5HT 3 receptor antagonist for the treatment of nausea and vomiting induced by cytostatics and radiotherapy].
Herrstedt
J
J
Onkologisk afdeling R, Københavns Amts Sygehus i Herlev.
Ersbøll
J
J
Dombernowsky
P
P
D000932:Antiemetics / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000009:adverse effects; D006801:Humans; D007093:Imidazoles / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000628:therapy; D017294:Ondansetron; D011878:Radiotherapy / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced
D000932:Antiemetics; D000970:Antineoplastic Agents; D007093:Imidazoles; D017294:Ondansetron
Ondansetron--en 5-HT3 receptorantagonist til behandling af cytostatika- og stråleterapi- induceret kvalme og opkastning.